Development of antifibrotic therapy for stricturing Crohn's disease: Lessons from randomized trials in other fibrotic diseases

SN Lin, R Mao, C Qian, D Bettenworth… - Physiological …, 2022 - journals.physiology.org
Intestinal fibrosis is considered an inevitable complication of Crohn's disease (CD) that
results in symptoms of obstruction and stricture formation. Endoscopic or surgical treatment …

Development of antifibrotic therapy for stricturing Crohn's disease: lessons from randomized trials in other fibrotic diseases

SN Lin, R Mao, C Qian, D Bettenworth… - Physiological …, 2022 - pubmed.ncbi.nlm.nih.gov
Intestinal fibrosis is considered an inevitable complication of Crohn's disease (CD) that
results in symptoms of obstruction and stricture formation. Endoscopic or surgical treatment …

Development of antifibrotic therapy for stricturing Crohn's disease: lessons from randomized trials in other fibrotic diseases.

SN Lin, R Mao, C Qian, D Bettenworth, J Wang… - Physiological …, 2021 - europepmc.org
Development of antifibrotic therapy for stricturing Crohn's disease: lessons from randomized
trials in other fibrotic diseases. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …

Development of antifibrotic therapy for stricturing Crohn's disease: lessons from randomized trials in other fibrotic diseases

SN Lin, R Mao, C Qian, D Bettenworth… - Physiological …, 2022 - journals.physiology.org
Intestinal fibrosis is considered an inevitable complication of Crohn's disease (CD) that
results in symptoms of obstruction and stricture formation. Endoscopic or surgical treatment …

Development of antifibrotic therapy for stricturing Crohn's disease: lessons from randomized trials in other fibrotic diseases.

SN Lin, R Mao, C Qian, D Bettenworth, J Wang… - Physiological …, 2021 - europepmc.org
Development of antifibrotic therapy for stricturing Crohn's disease: lessons from randomized
trials in other fibrotic diseases. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …